alfuzosin hydrochloride

Generic: alfuzosin hydrochloride

Labeler: apotex corp.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name alfuzosin hydrochloride
Generic Name alfuzosin hydrochloride
Labeler apotex corp.
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

alfuzosin hydrochloride 10 mg/1

Manufacturer
Apotex Corp.

Identifiers & Regulatory

Product NDC 60505-2850
Product ID 60505-2850_5632aa3d-c35f-10fe-3ad1-7d1632a1c1c8
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA079013
Listing Expiration 2026-12-31
Marketing Start 2023-09-08

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 605052850
Hyphenated Format 60505-2850

Supplemental Identifiers

RxCUI
861132
UNII
75046A1XTN

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name alfuzosin hydrochloride (source: ndc)
Generic Name alfuzosin hydrochloride (source: ndc)
Application Number ANDA079013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 10 mg/1
source: ndc
Packaging
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-2850-9)
source: ndc

Packages (1)

Ingredients (1)

alfuzosin hydrochloride (10 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "5632aa3d-c35f-10fe-3ad1-7d1632a1c1c8", "openfda": {"unii": ["75046A1XTN"], "rxcui": ["861132"], "spl_set_id": ["26fcc267-c8d7-e059-1bcf-830dded43690"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-2850-9)", "package_ndc": "60505-2850-9", "marketing_start_date": "20230908"}], "brand_name": "Alfuzosin Hydrochloride", "product_id": "60505-2850_5632aa3d-c35f-10fe-3ad1-7d1632a1c1c8", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "60505-2850", "generic_name": "Alfuzosin Hydrochloride", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Alfuzosin Hydrochloride", "active_ingredients": [{"name": "ALFUZOSIN HYDROCHLORIDE", "strength": "10 mg/1"}], "application_number": "ANDA079013", "marketing_category": "ANDA", "marketing_start_date": "20230908", "listing_expiration_date": "20261231"}